KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to 0.84.

  • Amneal Pharmaceuticals' Asset Utilization Ratio rose 8.69% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 8.69%. This contributed to the annual value of 0.80 for FY2024, which is 21.71% up from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Asset Utilization Ratio is 0.84, which was down 0.56% from 0.84 recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Asset Utilization Ratio peaked at 0.84 during Q2 2025, and registered a low of 0.50 during Q1 2021.
  • In the last 3 years, Amneal Pharmaceuticals' Asset Utilization Ratio had a median value of 0.75 in 2024 and averaged 0.74.
  • Data for Amneal Pharmaceuticals' Asset Utilization Ratio shows a peak YoY climbed of 25.21% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Asset Utilization Ratio stood at 0.53 in 2021, then increased by 8.98% to 0.58 in 2022, then grew by 15.96% to 0.67 in 2023, then grew by 20.03% to 0.80 in 2024, then grew by 8.69% to 0.84 in 2025.
  • Its Asset Utilization Ratio stands at 0.84 for Q3 2025, versus 0.84 for Q2 2025 and 0.82 for Q1 2025.